Diane Weiser | executive |
Robert I. Blum | executive |
Fady Malik | executive |
Stuart Kupfer | executive |
Andrew Callos | executive |
Robert Wong | executive |
Kyuwon Choi | analyst |
Srikripa Devarakonda | analyst |
Tessa Romero | analyst |
Roanna Clarissa Ruiz | analyst |
Salim Syed | analyst |
Lee Hung | analyst |
Mayank Mamtani | analyst |
Jason Butler | analyst |
Cameron Bozdog | analyst |
Carter L. Gould | analyst |
Yasmeen Rahimi | analyst |
Serge Belanger | analyst |
Ashwani Verma | analyst |
Sean McCutcheon | analyst |
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics' First Quarter 2024 Conference Call. At this time, I would like to inform you that this call is being recorded [Operator Instructions].
I will now turn the call over to Diane Weiser, Cytokinetics' Senior Vice President of Corporate Affairs. Please go ahead.
Good afternoon, and thanks for joining us on the call today.